Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.

Description

Revolutionizing the way heart failure is identified, the EchoGo Heart Failure platform leverages artificial intelligence to enhance precision in detecting HFpEF from echocardiograms. Developed in partnership with the Mayo Clinic, this innovative solution simplifies the detection process, achieving remarkable accuracy from just a single apical 4-chamber view, addressing the challenges that have long hindered identification of this condition. As the first AI-driven platform dedicated to HFpEF detection in echocardiography, Ultromics sets the standard in this field, making it a leader in the use of AI for cardiac imaging. Our advanced technology not only allows for earlier and more efficient identification of heart failure but also aims to improve the overall quality of life for patients. Through our user-friendly and secure cloud-based Software-as-a-Service (SaaS) platform, Ultromics seamlessly integrates with existing echocardiography systems, providing labs with the tools necessary for precise heart failure detection and effective risk stratification. This capability has the potential to significantly lower hospitalization rates related to heart failure, ultimately benefiting healthcare systems and patients alike. As we continue to innovate, our commitment remains to transform cardiac care for the better.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

BenevolentAI

Founded

2013

Country

Luxembourg

Website

www.benevolent.com

Vendor Details

Company Name

Ultromics

Country

United Kingdom

Website

www.ultromics.com

Product Features

Medical Imaging

Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management

Alternatives

Alternatives

Merlin CardioMotion Reviews

Merlin CardioMotion

Central Data Networks
HeartLab Pulse Reviews

HeartLab Pulse

HeartLab